查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197922

外周静脉导管市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)

Peripheral Intravenous Catheters Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 122 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，全球外周静脉导管市场预计将以约 6.5% 的复合年增长率增长。

全球 COVID-19 病例数量的激增和封锁情况对市场产生了重大影响，因为治疗、诊断和手术等服务最初被搁置以防止 COVID-19 的传播。曾是。 然而，随着全球 COVID-19 病例数的增加，它也导致住院人数增加。 随着政府和医疗机构提高对 COVID-19 患者的护理效率，医院和急诊室对导管的需求量很大。 2021 年 7 月发表在国家医学图书馆的一项研究发现，在门诊和门诊诊所，89.2% 的血管外科医生报告了更短的咨询时间 (71%) 和使用远程医疗服务 (81.1%) 等变化。 因此，血管手术和非 COVID-19 患者住院的减少阻碍了 COVID-19 期间的市场增长。 此外，随着所有限制的解除和门诊治疗数量的增加，预计市场扩张将在预测期内恢復。

心血管、神经和泌尿系统疾病患病率上升，导管中先进材料的使用增加，以及对微创手术的需求增加，推动了市场的发展。 在过去的 30 年里，心血管、泌尿系统和神经系统疾病一直是全球死亡率和发病率的主要原因。 在预测期内，越来越多地使用外周静脉导管治疗这些涉及住院的慢性疾病预计将推动市场。 例如，根据 2021 年 7 月发表在《循环》杂誌上的一项研究，外周动脉疾病 (PAD) 影响着全世界超过 2.3 亿人，并导致多种有害疾病，包括冠心病和中风。与临床风险增加相关结果。 因此，预计 PAD 的全球高发病率及其相关风险因素将在预测期内推动对外周静脉导管的需求。

此外，根据联合国2021年2月公布的数据，到2020年，地球上将有超过10亿人，即近六分之一的人患有阿尔茨海默病、帕金森病、中风和多发性硬化症。据说患有癫痫、癫痫性偏头痛、脑外伤、神经感染等神经系统疾病。 据同一消息人士称，到2020年，全球将有6200万人患有脑血管病，5000万人患有癫痫症，3.26亿人患有偏头痛，2400万人患有阿尔茨海默病和其他痴呆症。 因此，预计心血管和神经系统疾病患病率上升将推动市场增长。

因此，上述所有因素都有望在预测期内推动市场增长。 然而，与外周静脉导管相关的风险和并发症可能会阻碍全球外周静脉导管市场的增长。

外周静脉导管市场趋势

集成/封闭式导管主导市场，预计在预测期内将继续如此

在整个预测期内，集成/封闭式导管预计将主导外周静脉导管市场。 越来越多地采用有助于在计算机断层扫描 (CT) 期间注入造影剂的封闭式导管是该领域的增长动力。 这些导管由聚氨酯材料製成，可承受超过 300 磅/平方英寸 (psi) 的压力。

根据 2022 年 8 月发表在《英国护理杂誌》上的一项研究，紧密/整体导管可降低医护人员接触患者血液的风险，并允许安全地采集血液样本。 它可以防止回流到插管尖端，降低阻塞风险和多次插入的需要。 此外，设备在插入后必须保持稳定，以尽量减少血管内的微动，微动会损坏内膜并导致机械性静脉炎。 因此，由于上述优势，紧配合/整体导管预计在预测期内需求增加，从而推动该细分市场的增长。

此外，市场参与者的各种战略活动（例如产品发布、併购和合作伙伴关係）预计将在预测期内推动细分市场的增长。 例如，2022年7月，B. Braun Medical Inc.（B. Braun）推出了Introcan Safety 2 IV Catheter，能够进行单次血液控制。 Introcan Safety 2 IV 导管是 B. Braun 的最新创新，旨在降低针刺伤和血液暴露的风险，使临床医生的 IV 通路更安全。

因此，上述所有因素预计将在预测期内推动该细分市场的增长。

北美主导市场，预计在预测期内将继续保持这一势头

北美占据了大部分市场份额。 该地区受到慢性病增加和人口老龄化的困扰。 北美拥有先进的医疗保健设施和广泛的保险报销范围，有助于在该地区占据较大的市场份额。 例如，根据 Alzheimers.org 的数据，到 2021 年，美国将有 620 万 65 岁及以上的美国人患有与阿尔茨海默病相关的痴呆症。 帕金森基金会还估计，到 2020 年将有近 100 万美国人患有帕金森病 (PD)。 据同一消息来源称，每年有近 60,000 名美国人被诊断出患有帕金森症。 因此，预计神经系统疾病患病率上升将增加对外周静脉导管的需求，从而推动市场增长。

此外，人口老龄化更容易患心血管和神经系统疾病，因此预计老年人口的增加将推动市场增长。 根据加拿大统计局的一份报告，到 2021 年 7 月，大约 18.5% 的加拿大人口将超过 65 岁，高于 2020 年 7 月的 17.5%。 此外，根据 2020 年全球人口老龄化报告，美国 65 岁及以上人口超过 4600 万，预计到 2050 年这一数字将增长到近 9000 万。 此外，预计 2020 年至 2030 年间老年人口将增加近 1800 万。 因此，预计易患心脏病的老年人口增加将增加对外周静脉导管的需求，从而推动该地区的市场增长。

此外，主要市场参与者推出的产品将支持市场扩张。 例如，2022年9月，B. Braun Medical Inc.（B. Braun）宣布收购Starboard Medical, Inc.专有的Clik-FIX导管固定装置产品组合。 B.Braun 的收购扩展了公司产品和项目创新的历史，以改善外周静脉 (IV) 治疗的患者体验和结果。 因此，上述所有因素预计将推动该地区的市场增长。

外周静脉导管市场竞争者分析

外周静脉导管市场竞争激烈，既有本地公司也有跨国公司。 由于技术进步，中小型企业将重点放在市场渗透和获得市场份额上。 目前市场上的公司包括 B. Braun Melsungen AG、BD、ICU Medical、Smiths Medical、Teleflex Incorporated、Terumo IS 和 Vygon SA。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 心血管、神经和泌尿系统疾病的患病率增加
    • 增加导管中使用的尖端材料
    • 增加微创手术的频率
  • 市场製约因素
    • 与导管相关的风险和并发症
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 集成/闭合导管
    • 外周插入导管
  • 最终用户
    • 医院
    • 门诊手术中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • B. Braun Melsungen AG
    • BD
    • ICU Medical（Smiths Medical）
    • Lineus Medical
    • Teleflex Incorporated
    • Terumo IS
    • Vygon SA
    • NIPRO Medical Corporation
    • VOGT Medical
    • RenovoRx Inc.
    • Retractable Technologies Inc.
    • MedSource Labs

第7章 市场机会与今后动向

简介目录
Product Code: 68187

The global peripheral intravenous catheters market is anticipated to grow with a CAGR of nearly 6.5% during the forecast period.

The escalating number of COVID-19 cases worldwide, as well as the lockdown scenario, had a substantial influence on the market, initially due to on-hold services such as treatment, diagnostic, and surgical services, to prevent the spread of COVID-19. However, the growing number of COVID-19 cases worldwide contributed to an increase in the number of in-patient admissions. Catheters were in high demand in hospitals and emergency clinics as governments and healthcare institutions sought to improve the efficiency of medical treatment for COVID-19 patients. According to the study published in the National Library of Medicine in July 2021, in ambulatory care and outpatient clinics, 89.2% of vascular surgeons reported changes to their practice, including fewer hours (71%) and the use of telehealth services (81.1%). Thus, the decline in vascular procedures and non-COVID-19 patient admission hampered the growth of the market during COVID-19. Additionally, the market is anticipated to resume its expansion throughout the projection period as all restrictions are eliminated, and the number of outpatient treatments rises.

The market is driven by the rising prevalence of cardiovascular, neurology, and urology disorders, rising usage of advanced materials in the catheter, and growing demand for minimally invasive surgeries. Cardiovascular, urology, and neurology diseases have become the most dominant cause of mortality and morbidity in the world during the last three decades. Increasing utilization of peripheral intravenous catheters in treating these chronic diseases, leading to hospitalization, is anticipated to drive the market over the forecast period. For instance, per the study article published in Circulation in July 2021, peripheral artery disease (PAD) affects over 230 million persons globally and is linked to an elevated risk of various adverse clinical outcomes, including coronary heart disease, stroke, and others. As a result, the high global incidence of PAD and its associated risk factors are projected to drive demand for peripheral IV catheters over the forecast period.

Additionally, according to data published by the United Nations, in February 2021, in 2020, over 1 billion individuals, or nearly one in every six persons on the planet, would suffer from neurological disorders such as Alzheimer's and Parkinson's disease, strokes, multiple sclerosis, epilepsy migraine, brain traumas, and neuro infections. According to the same source, in 2020, 62 million individuals suffered from cerebrovascular disease, 50 million from epilepsy, 326 million from migraine, and 24 million from Alzheimer's disease and other dementias across the globe. Thus, the growing prevalence of cardiovascular and neurological diseases is expected to boost market growth.

Thus, all aforementioned factors are expected to boost market growth over the forecast period. However, risks and complications associated with peripheral intravenous catheters may hinder the growth of the global peripheral intravenous catheter market.

Peripheral Intravenous Catheters Market Trends

Integrated/Closed Catheters Dominates the Market and Expected to Continue the Same during the Forecast Period

Integrated/closed catheters are expected to dominate the peripheral intravenous catheter market through the forecast period. The increasing adoption of closed catheters that help inject contrast media during computed tomography (CT) is acting as a driving factor for this segment's growth. These catheters are made of polyurethane material and can withstand pressures exceeding 300 pounds per square inch (psi).

According to the study published in the British Journal of Nursing in August 2022, a close/integrated catheter decreases the risk of the healthcare professional coming into contact with the patient's blood and allows for the safe collection of blood samples. It can help prevent backflow into the cannula tip, lowering the danger of blockage and the requirement for several insertions. It is also vital that the device remains stable after insertion to minimize micro-movements within the vessel (which can damage the tunica intima, which can result in mechanical phlebitis. Thus, due to the above benefits, the close/integrated catheter is expected to increase its demand over the forecast period, thereby boosting segment growth.

Furthermore, various strategic activities by market players, such as product launches, mergers, acquisitions, and partnerships, are likely to boost segment growth over the forecast period. For instance, in July 2022, B. Braun Medical Inc. (B. Braun) introduced the Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is B. Braun's latest innovation for making IV access safer for clinicians by lowering the risk of needlestick injuries and blood exposure.

Thus, all the above-mentioned factors are expected to boost segment growth over the forecast period.

North America Dominates the Market and Expected to Continue the Same during the Forecast Period

North America held the majority of the market share. The region suffers from rising chronic diseases and a growing senior population. North America has sophisticated healthcare facilities, and the reimbursement coverage contributes to the large market share of the region. For instance, according to data from Alzheimers.org, 6.2 million Americans aged 65 and older were thought to have Alzheimer's-related dementia in the United States in 2021. Also, the Parkinson's Foundation estimated that nearly 1 million Americans were living with Parkinson's disease (PD) in 2020. As per the same source, nearly 60,000 Americans are diagnosed with Parkinson's disease every year. Thus, the growing prevalence of neurological diseases is expected to boost the demand for peripheral IV catheters, thereby boosting the market growth.

Furthermore, the geriatric population is more prone to cardiovascular and neurological diseases, and thus growing this population is likely to support the growth of the market. As per the Government of Canada Statistics report, as of July 2021, around 18.5% of the Canadian population was aged above 65 years, increasing from 17.5% in July 2020. Additionally, according to the World Population Ageing in 2020, in the United States, there are more than 46 million older adults aged 65 and up; by 2050, that number is expected to rise to nearly 90 million. The number of older adults is expected to rise by nearly 18 million between 2020 and 2030. Thus, the rising geriatric population more prone to cardiac diseases is expected to rise in demand for peripheral IV catheters, thereby driving the market growth in the region.

Furthermore, product launches by the key market players support market expansion. For instance, in September 2022, B. Braun Medical Inc. (B. Braun) reported the acquisition of Starboard Medical, Inc.'s unique Clik-FIX catheter securement device portfolio. The acquisition by B. Braun expands on the company's history of product and program innovation to improve the patient experience and outcomes with peripheral intravenous (IV) therapy. Thus, all the above-mentioned factors are expected to drive market growth in the region.

Peripheral Intravenous Catheters Market Competitor Analysis

The market for peripheral intravenous catheters is highly competitive and consists of global as well as local players. Due to technological advancements, small and mid-sized companies are focusing on market penetration to grab market share. Some of the companies which are currently present in the market are B. Braun Melsungen AG, BD, ICU Medical, Smiths Medical, Teleflex Incorporated, Terumo IS, Vygon SA.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular, Neurology, and Urology Disorders
    • 4.2.2 Growing Usage of the Advanced Materials in the Catheters
    • 4.2.3 Growing Frequency of Minimally Invasive Procedures
  • 4.3 Market Restraints
    • 4.3.1 Risks and Complications Associated with the Catheters
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Integrated/Closed Catheters
    • 5.1.2 Peripheral Insertion Catheters
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 BD
    • 6.1.3 ICU Medical (Smiths Medical)
    • 6.1.4 Lineus Medical
    • 6.1.5 Teleflex Incorporated
    • 6.1.6 Terumo IS
    • 6.1.7 Vygon SA
    • 6.1.8 NIPRO Medical Corporation
    • 6.1.9 VOGT Medical
    • 6.1.10 RenovoRx Inc.
    • 6.1.11 Retractable Technologies Inc.
    • 6.1.12 MedSource Labs

7 MARKET OPPORTUNITIES AND FUTURE TRENDS